Effects of Dapagliflozin Adjunct to Insulin on Glycemic Variations in Patients with Newly Diagnosed Type 2 Diabetes: A Randomized, Controlled, Open-Labeled Trial

Table 5

Insulin doses required by patients in the two groups.

Parameter	Therapy for 1 week		value	Therapy for 5 weeks		value
	DAPA+CSII	CSII		DAPA+CSII	CSII
Total (U/kg)			0.45			0.02
Basal (U/kg)			0.49			0.03
Total bolus (U/kg)			0.50			0.03
Bolus (B)			0.56			0.05
Bolus (L)			0.60			0.03
Bolus (D)			0.44			0.05

Bolus (B): bolus breakfast; bolus (L): bolus lunch; bolus (D): bolus dinner.